Darwin IP Advisors (darwinipadvisors.com) is pleased to announce the completion of an intellectual property transaction between Commence Bio, Inc. (California and Maryland) and SanBio, Inc. (California and Tokyo, JP). We are excited about the redeployment of this innovative Mesenchymal Stromal Cell (MSC) technology and know-how that may lead to future anti-inflammatory therapies and cancer cell immunotherapies developed by SanBio.
SanBio, Inc. is appreciative of the efforts provided by Darwin IP Advisors to complete this transaction in an efficient and timely manner.